Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 2 |
2004 | 1 |
2005 | 1 |
2006 | 1 |
2007 | 2 |
2008 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival.
Pigment Cell Melanoma Res. 2008 Oct;21(5):534-44. doi: 10.1111/j.1755-148X.2008.00491.x. Epub 2007 Jul 28.
Pigment Cell Melanoma Res. 2008.
PMID: 18715233
Free PMC article.
Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells.
Liu J, Suresh Kumar KG, Yu D, Molton SA, McMahon M, Herlyn M, Thomas-Tikhonenko A, Fuchs SY.
Liu J, et al. Among authors: molton sa.
Oncogene. 2007 Mar 22;26(13):1954-8. doi: 10.1038/sj.onc.1209994. Epub 2006 Sep 25.
Oncogene. 2007.
PMID: 17001349
Free PMC article.
Item in Clipboard
ERK1/2 and p38 cooperate to induce a p21CIP1-dependent G1 cell cycle arrest.
Todd DE, Densham RM, Molton SA, Balmanno K, Newson C, Weston CR, Garner AP, Scott L, Cook SJ.
Todd DE, et al. Among authors: molton sa.
Oncogene. 2004 Apr 22;23(19):3284-95. doi: 10.1038/sj.onc.1207467.
Oncogene. 2004.
PMID: 14981547
Item in Clipboard
Activation of ERK1/2 by deltaRaf-1:ER* represses Bim expression independently of the JNK or PI3K pathways.
Weston CR, Balmanno K, Chalmers C, Hadfield K, Molton SA, Ley R, Wagner EF, Cook SJ.
Weston CR, et al. Among authors: molton sa.
Oncogene. 2003 Mar 6;22(9):1281-93. doi: 10.1038/sj.onc.1206261.
Oncogene. 2003.
PMID: 12618753
Item in Clipboard
Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3'-kinase (PI3K) pathway is inhibited.
Molton SA, Todd DE, Cook SJ.
Molton SA, et al.
Oncogene. 2003 Jul 24;22(30):4690-701. doi: 10.1038/sj.onc.1206692.
Oncogene. 2003.
PMID: 12879014
Item in Clipboard
The conditional kinase DeltaMEKK1:ER* selectively activates the JNK pathway and protects against serum withdrawal-induced cell death.
Molton SA, Weston C, Balmanno K, Newson C, Todd DE, Garner AP, Cook SJ.
Molton SA, et al.
Cell Signal. 2005 Nov;17(11):1412-22. doi: 10.1016/j.cellsig.2005.02.006.
Cell Signal. 2005.
PMID: 15893455
Item in Clipboard
Cite
Cite